Anti-allergic activity of cyclosporin-A metabolites and their interaction with the parent compound and FK 506

International Journal of Immunopharmacology

Volumn 18, Issue 4, 1996, Pages 263-270

  Ezeamuzie, Charles I ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Allergy; Cyclosporin A; FK 506; Hexoseaminidase; Metabolites; RBL cells

Indexed keywords

ANTIALLERGIC AGENT; BETA N ACETYLHEXOSAMINIDASE; CYCLOSPORIN A; CYCLOSPORIN A [1 (3,8 DIHYDROXY 2 METHYLAMINO 4 METHYL 6 OCTENOIC ACID)]; CYCLOSPORIN A [4 LEUCINE]; DRUG METABOLITE; TACROLIMUS;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME RELEASE; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030130437     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(96)84506-1     Document Type: Article

References (39)

1. Alexander, A. G., Barnes, N. C. & Kay, A. B. (1992) Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet, 339, 324-328.
2. Barsumian, E. L., Iserky, C., Petrino, M. G. & Siraganian, R. P. (1981) IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur. J. Immunol, 11, 317-323.
3. Baumann, G. (1992) Molecular mechanism of immunosuppressive agents. Transplant. Proc., 24(4) Suppl. 2, 4-7.
4. Beaven, M. A., Maeyama, K., Wolde-mussie, E., Lo, T. N., Ali, H. & Cunha-Melo, J. R. (1987) Mechanism of signal transduction in mast cells and basophils: studies with RBL-2H3 cells. Agents and Actions, 20, 137-145.
5. Berenbaum, M. C. (1977) Synergy, additivism and antagonism in immunosuppression. Clin. exp. Immunol., 28, 1-18.
6. Borel, J. F., Feurer, C., Gubler, H. U. & Stahelin, A. (1976) Biological effects of cyclosporin A: a new anti-lymphocyte agent. Agents Action, 6, 468-475.
7. Caroni, P., Rothenfluh, A., McGlynn, E. & Schneider, C. (1991) S-Cyclophilin: new member of the cyclophilin family associated with the secretory pathway. J. biol. Chem., 266, 10739-10742.
8. Copeland, K. R., Yatscoff, R. W., Rush, D. & Jeffery, J. R. (1989) Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites. Transplant. Proc., 21, 1449-1452.
9. De Paulis, A., Cirillo, R., Ciccarelli, A., Condorelli, M. & Marone, G. (1991) FK 506, a potent novel inhibitor of the release of pro-inflammatory mediators from human FceRI+ cells. J. Immunol., 146, 2374-2381.
10. Durette, P. L., Boger, J., Dumont, F., Firestone, R., Frankshun, R. A., Koprak, S. L., Lin, C. S., Melino, M. R., Pessolano, A. A., Pisano, J., Schmidt, J. A., Sigal, N. H., Staruch, M. J. & Witzel, B. E. (1988) A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues. Transplant. Proc., 20 Suppl. 2, 51-57.
11. Dvorak, A. M., Monahan, R. A., Osage, J. E. & Dickersin, G. R. (1980) Transmission electron micrographic studies. II. Immunologic inflammatory response. Alteration of mast cells, basophils, eosinophils and the microvasculature. Human Pathol., 11, 606-619.
12. Ezeamuzie, I. C. & Assem, E. S. K. (1989) Inhibition of histamine release from human basophils and rat peritoneal mast cells by cyclosporin-A. Br. J. Pharmacol., 96, 275P.
13. Ezeamuzie, I. C. & Assem, E. S. K. (1990) Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophil and rat basophilic leukemia cells (RBL-2H3). Immunopharmacology, 20, 31-43.
14. Ezeamuzie, C.I., Assem, E.S.K. & Bahl, A.L. (1992). Comparative study of the anti-allergic and immunosuppressive activities of cyclosporin A and some of its analogues. Agents and Actions, Special Conference Issue, C275-C278.
15. Fahr, A., Hiestand, P. & Ryffel, B. (1990) Studies on the biological activities of Sandimmun metabolites in humans and animal models: review and original experiments. Transplant. Proc., 22, 1116-1124.
16. Feutren, G. (1992) Clinical experience with sandimmune (CSA) in autoimmune diseases. Transplant. Proc., 24 Suppl. 2, 55-60.
17. Fewtrell, C.M. & Metzger, H. (1981). Stimulus-secretion coupling in rat basophilic leukemia cells. In Biochemistry of Acute Allergic Reactions (eds Becker, E.L., Simon, A.S., and Austen, K.F.), pp. 295-314. Liss, New York.
18. Friedman, J. & Weissman, I. (1991) Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CSA. Cell, 66, 799-806.
19. Handschumacher, R. E., Harding, I. M., Rice, J., Drugge, W. & Speicher, D. W. (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science, 226, 544-547.
20. Howell, T. W. & Gomperts, B. D. (1987) Rat mast cells permeabilized with streptolysin-O secrete histamine in response to calcium at concentrations buffered in the micromolar range. Biochim. biophys. Acta, 927, 177-186.
21. 2+ fluxes. J. Immunol., 144, 2659-2664.
22. Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H. & Ochiai, T. (1987) FK 506, a novel immunosuppressant isolated from a streptomyces. II. Immunosuppressive effect in vitro. J. Antibiot., 40, 1256-1265.
23. Kulczycki, A. C, Isersky, C. & Metzger, H. (1974) The interaction of IgE with rat basophilic leukemia cells. I. Evidence of specific binding of IgE. J. exp. Med, 139, 600-616.
24. Kunzendorf, U., Brockmoeller, J., Jochimsen, F., Roots, I. & Offermann, G. (1989) Immunosuppressive properties of cyclosporin metabolites. Lancet, i, 734-735.
25. Lensmeyer, G. L., Wiebe, D. A. & Carlson, I. H. (1988) Deposition of nine metabolites of cyclosporine in human tissues, bile, urine, and whole blood. Transplant. Proc., 20, 614-622.
26. Masuda, K., Nakajima, A., Urayama, A., Nakae, K., Kogure, M. & Inaba, G. (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcets disease. Lancet, i, 1093-1095.
27. Maurer, G. (1985) Metabolism of cyclosporine. Transplant. Proc., 17, 19-26.
28. Morita, Y. & Siraganian, R. P. (1981) Inhibition of IgE-mediated histamine release from rat basophilic leukemia cells and rat mast cells by inhibitors of transmethylation. J. Immunol., 127, 1339-1344.
29. Price, E. R., Zydowsky, L. D., Jin, M. J., Baker, C. H., McKeon, F. D. & Walsh, C. T. (1991) Human cyclophilin B. A second cyclophilin gene encodes a peptidyl-propyl isomerase with a signal sequence. Proc. natn. Acad. Sci. U.S.A., 88, 1903-1907.
30. Schreiber, S. L. (1991) Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science, 251, 283-287.
31. Schultz, J. C., Lensmeyer, G. L., Wendal, T. D., Shahidi, N. T., Wiebe, D. A., Carlson, I. H. (1991) Synergistic and antagonistic effects of combinations of cyclosporin-A and its metabolites on the inhibition of phytohaemagglutinin-induced lymphocyte transformation in vitro. Biochem. Pharmacol., 42, 1403-1410.
32. Sewing, K.-Fr., Christians, U., Kohlhaw, K., Radeke, H., Strottmeyer, S., Kownatzki, R., Budniak, J., Schottmann, R., Bleck, J. S., Almeida, V. M. F., Deters, M., Wonigeit, K. & Pichlmayr, R. (1990) Biologic activity of cyclosporine metabolites. Transplant. Proc., 22, 1129-1134.
33. Siekierka, J. J., Hung, S. H. Y., Poe, M., Lin, C. H. & Sigal, N. H. (1989) A cytosolic binding protein for the immunosuppressant FK 506 has peptidyl-propyl isomerase activity but is distinct from cyclophilin. Nature, 341, 755-757.
34. Sigal, N. H. & Dumont, F. J. (1992) Cyclosporin A, FK-506 and rapamycin: pharmacologic probes of lymphocyte signal transduction. A. Rev. Immunol., 10, 519-560.
35. Takahashi, N., Hayano, T. & Suzuki, M. (1989) Peptidyl-propyl cis-trans isomerase is the cyclosporin-A binding protein cyclophilin. Nature, 337, 473-475.
36. 2 release from human lung mast cells by cyclosporin A. Int. Arch. Allergy appl. Immunol., 88, 253-255.
37. Tocci, M. J., Matkovich, D. A., Collier, K. A., Kwok, P., Dumont, F., Lin, S., Degudicibus, S., Siekierka, M., Chin, J. & Hutchinson, N. I. (1989) The immunosuppressant FK 506 selectively inhibits expression of early T cell activation genes. J. Immunol., 143, 718-726.
38. Tugwell, P., Bombardier, C., Gent, M., Bennett, M., Bensen, W. G., Carette, S., Esdaile, J. M., Klinkhof, F. A. V. & Kraug, G. R. (1990) Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet, 355, 1051-1055.
39. Zeevi, A., Eiras, G., Burckart, G., Makowka, L., Venkataramanan, R., Wang, C. P., Van Thiel, D. H., Murase, N., Starzi, T. E. & Duquesnoy, R. (1988) Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells. Transplant. Proc., 20 Suppl. 2, 115-121.